Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol

NCT00830882 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Asthma

Interventions

DRUG: levosalbutamol
DRUG: racemic salbutamol
DRUG: placebo

Sponsor

University of Dundee